Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Motor Activity 9Neoplasms 6Pancreatic Neoplasms 3Lung Neoplasms 3Breast Neoplasms 3Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Rectal Neoplasms 1Peripheral Nervous System Diseases 1Neurocognitive Disorders 1Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Cognitive Dysfunction 1

Interventions

Fluorouracil 10Oxaliplatin 8Capecitabine 8pembrolizumab 6Specimen Handling 6Nivolumab 6Leucovorin 6trastuzumab deruxtecan 5Magnetic Resonance Spectroscopy 5Paclitaxel 4Cisplatin 4Biopsy 4fludarabine 3aldesleukin 3Trastuzumab 3Cyclophosphamide 3zolbetuximab 2fludarabine phosphate 2Ramucirumab 2Folfox protocol 2Docetaxel 2zimberelimab 1zanidatamab 1ulixertinib 1tucatinib 1trifluridine tipiracil drug combination 1trastuzumab biosimilar HLX02 1trametinib 1toripalimab 1tislelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Exercise × 30 days × Clear all
NCT07596732 2026-05-19

SUNRISE

AdventHealth Translational Research Institute

Phase NA Not yet recruiting
120 enrolled
GastrointestinalThoracic

Colonic Neoplasms, Disease, Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡